Tuesday, January 12, 2016
BioPorto A/S says has entered into a distribution agreement with Siemens Healthcare, under which BioPorto will deliver an NGAL test adapted for Siemens Healthcare's BN II and BN ProSpec Systems.
Says expects to see an economic effect of this agreement in H2 2016.
reuters.com
